$1.81
0.074.02%
Last update: Nov 6, 4:45 AM
Polaryx Therapeutics Inc
PLYXNASDAQ
The average analyst price target for Polaryx Therapeutics is $7.50, 314.4% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $6 to $10. The latest change came on Aug 13, 2026, when Raymond James initiated coverage of Polaryx Therapeutics with a Strong Buy rating and a $6 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
